Updates on Multisystem Inflammatory Syndrome in Children (MIS-C): Epidemiology, Case Definition, and COVID-19 Vaccination
The fully captioned video and edited transcript will be posted within the next few days.
Click here to view the recording with the integrated audio transcript using the password below.
Password: 9r+6G%U8
“Please note special time of this COCA Call.”
This COCA Call will be held on Friday, March 27, 2020
This COCA Call will be held on Friday, March 27, 2020
Overview
The Council of State and Territorial Epidemiologists (CSTE) and the Centers for Disease Control and Prevention (CDC) have developed a new multisystem inflammatory syndrome in Children (MIS-C) surveillance case definition to help reduce misclassification and complexity. This CDC/CSTE MIS-C surveillance case definition is based on an extensive review of data from 2020–2022. MIS-C is a rare, but severe condition that may occur 2-6 weeks after acute SARS-CoV-2 infection. CDC has been actively involved in MIS-C surveillance, public health investigations, and development of resources to support the public health and healthcare community. The updated CSTE/CDC MIS-C case definition will become effective on January 1, 2023.
During this COCA Call, presenters will review MIS-C epidemiologic and clinical trends, provide a rationale and description of changes in criteria for the new CSTE/CDC MIS-C surveillance case definition compared with the 2020 CDC MIS-C case definition, and discuss information relating to MIS-C and COVID-19 vaccination.
Presenters
Angela Campbell, MD, MPH, FAAP, FPIDS, FIDSA
Medical Officer
Severe Respiratory Illness and Multisystem Inflammatory Syndrome (SIM) Team Lead
Epidemiology Branch
Coronavirus and Other Respiratory Viruses Division (proposed)
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Michael Melgar, MD
Medical Officer
Severe Respiratory Illness and Multisystem Inflammatory Syndrome (SIM) Team
Epidemiology Branch
Coronavirus and Other Respiratory Viruses Division (proposed)
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Anna Yousaf, MD
Medical Officer
Severe Respiratory Illness and Multisystem Inflammatory Syndrome (SIM) Team
Epidemiology Branch
Coronavirus and Other Respiratory Viruses Division (proposed)
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Call Materials
When:
Tuesday, July 26, 2022,
2:00 PM – 3:00 PM ET
Webinar Link:
https://www.zoomgov.com/j/1615119188
Passcode: 143543
Dial In:
US: +1 669 254 5252 or +1 646 828 7666 or +1 551 285 1373 or +1 669 216 1590
One-tap mobile:
US: +16692545252,,1615119188#,,,,*143543# or +16468287666,,1615119188#,,,,*143543#
Webinar ID: 161 511 9188
Add to CalendarDue to the high demand we anticipate for this COCA Call, we encourage participants to consider viewing on Facebook. To see the call live, please click on COCA’s Facebook Page.
When:
Thursday, December 8, 2022,
2:00 PM – 3:00 PM ET
Webinar Link:
https://www.zoomgov.com/j/1610894085
Webinar ID: 161 089 4085
Passcode: 510428
Telephone:
US: +1 669 254 5252 or +1 646 828 7666 or +1 669 216 1590 or +1 551 285 1373
One-tap mobile:
US: +16692545252,,1610894085#,,,,*510428# or +16468287666,,1610894085#,,,,*510428#